Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study

Eric Van Cutsem, Erika Martinelli, Stefano Cascinu, Alberto Sobrero, Maria Banzi, Jean-François Seitz, Carlo Barone, Marc Ychou, Marc Peeters, Baruch Brenner, Ralf Dieter Hofheinz, Evaristo Maiello, Thierry André, Andrea Spallanzani, Rocio Garcia-Carbonero, Yull E Arriaga, Udit Verma, Axel Grothey, Christian Kappeler, Ashok MiriyalaJoachim Kalmus, Alfredo Falcone, Alberto Zaniboni

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study'. Together they form a unique fingerprint.

Medicine & Life Sciences